These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6796436)

  • 1. Induction of ovulation and pregnancy with pulsatile luteinizing hormone releasing factor: dosage and mode of delivery.
    Reid RL; Leopold GR; Yen SS
    Fertil Steril; 1981 Nov; 36(5):553-9. PubMed ID: 6796436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL; Casper RF; Yen SS
    Am J Obstet Gynecol; 1979 Nov; 135(6):759-63. PubMed ID: 386801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of luteinizing hormone-releasing factor (lrf) in the initiation of lordosis behavior in the estrone-primed ovariectomized female rat.
    Moss RL; McCann SM
    Neuroendocrinology; 1975; 17(4):309-18. PubMed ID: 806824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of ovulation with subcutaneous pulsatile gonadotropin-releasing hormone: correlation with body weight and other parameters.
    Thomas AK; Mander J; Hale J; Walstab J; Forrest MS
    Fertil Steril; 1989 May; 51(5):786-90. PubMed ID: 2495993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile luteinizing hormone releasing hormone treatment for induction of ovulation. Radioimmunoassay of plasma LHRH and comparative study of subcutaneous versus intravenous routes of administration.
    Couzinet B; Lahlou N; Lestrat N; Bouchard P; Roger M; Schaison G
    J Endocrinol Invest; 1986 Apr; 9(2):103-8. PubMed ID: 3519743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anovulation of hypothalamic origin. Treatment by pulsatile injection of hypothalamic gonadotropin releasing hormone].
    Schaison G; Lahlou N; Couzinet B; George M; Bouchard P; Roger M
    Presse Med; 1984 Nov; 13(41):2511-5. PubMed ID: 6239242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful induction of follicular maturation and ovulation by prolonged treatment with LH-releasing hormone in women with anorexia nervosa.
    Nillius SJ; Fries H; Wide L
    Am J Obstet Gynecol; 1975 Aug; 122(8):921-8. PubMed ID: 1098466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile administration of gonadotropin-releasing hormone for induction of ovulation.
    Loucopoulos A; Ferin M; Vande Wiele RL; Dyrenfurth I; Linkie D; Yeh M; Jewelewicz R
    Am J Obstet Gynecol; 1984 Apr; 148(7):895-900. PubMed ID: 6424475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS; Seibel MM
    J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of pituitary gonadotropic function by an agonist of luteinizing hormone-releasing factor in the puerperium.
    Sheehan KL; Yen SS
    Am J Obstet Gynecol; 1979 Nov; 135(6):755-8. PubMed ID: 386800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ovulation with pulsatile luteinising hormone releasing hormone.
    Mason P; Adams J; Morris DV; Tucker M; Price J; Voulgaris Z; Van der Spuy ZM; Sutherland I; Chambers GR; White S
    Br Med J (Clin Res Ed); 1984 Jan; 288(6412):181-5. PubMed ID: 6419847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
    Saffan D; Seibel MM
    Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.